Targeting selective autophagy and beyond: From underlying mechanisms to potential therapies

J Adv Res. 2024 Nov:65:297-327. doi: 10.1016/j.jare.2024.05.009. Epub 2024 May 14.

Abstract

Background: Autophagy is an evolutionarily conserved turnover process for intracellular substances in eukaryotes, relying on lysosomal (in animals) or vacuolar (in yeast and plants) mechanisms. In the past two decades, emerging evidence suggests that, under specific conditions, autophagy can target particular macromolecules or organelles for degradation, a process termed selective autophagy. Recently, accumulating studies have demonstrated that the abnormality of selective autophagy is closely associated with the occurrence and progression of many human diseases, including neurodegenerative diseases, cancers, metabolic diseases, and cardiovascular diseases.

Aim of review: This review aims at systematically and comprehensively introducing selective autophagy and its role in various diseases, while unravelling the molecular mechanisms of selective autophagy. By providing a theoretical basis for the development of related small-molecule drugs as well as treating related human diseases, this review seeks to contribute to the understanding of selective autophagy and its therapeutic potential.

Key scientific concepts of review: In this review, we systematically introduce and dissect the major categories of selective autophagy that have been discovered. We also focus on recent advances in understanding the molecular mechanisms underlying both classical and non-classical selective autophagy. Moreover, the current situation of small-molecule drugs targeting different types of selective autophagy is further summarized, providing valuable insights into the discovery of more candidate small-molecule drugs targeting selective autophagy in the future. On the other hand, we also reveal clinically relevant implementations that are potentially related to selective autophagy, such as predictive approaches and treatments tailored to individual patients.

Keywords: Autophagy; Clinically relevant implementation; Human disease; Molecular mechanism; Selective autophagy; Small-molecule drug.

Publication types

  • Review

MeSH terms

  • Animals
  • Autophagy* / drug effects
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism
  • Humans
  • Metabolic Diseases / drug therapy
  • Metabolic Diseases / metabolism
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism
  • Neurodegenerative Diseases* / drug therapy
  • Neurodegenerative Diseases* / metabolism